on August 25, 2003
Published online before print August 25, 2003, doi: 10.1161/01.CIR.0000087432.63671.2E
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 7, 2002
From the Department of Cardiology, Nuclear Cardiology Unit (C.A.W., P.K., G.F., P.A.K.), University Hospital, and the Institute of Physiology (M.S., C.S.), University of Zurich, Zurich, Switzerland. * To whom correspondence should be addressed. E-mail: pak{at}usz.ch.
Background--Although no data exist on the effect of altitude exposure on coronary flow reserve (CFR), patients with coronary artery disease (CAD) are advised not to exceed moderate altitudes of Methods and Results--In 10 healthy controls and 8 patients with CAD, MBF was measured by positron emission tomography and 15O-labeled water at rest, during adenosine stress, and after supine bicycle exercise. This protocol was repeated during inhalation of a hypoxic gas mixture corresponding to an altitude of 4500 m (controls) and 2500 m (CAD). Workload was targeted to comparable heart rate-blood pressure products at normoxia and hypoxia. Resting MBF increased significantly in controls at 4500 m (+24%, P<0.01) and in CAD patients at 2500 m (+24%, P<0.05). Altitude had no influence on adenosine-induced hyperemia and CFR. Exercise-induced hyperemia increased significantly in controls (+38%, P<0.01) at 4500 m (despite a reduction in workload, -28%, P<0.0001) but not in CAD patients at 2500 m (moderate decrease in workload, -11%, P<0.05). Exercise-induced reserve was preserved in controls (+10%, P=NS) but decreased in CAD patients (-18%, P<0.005). Conclusions--At 2500 m altitude, there is a significant decrease in exercise-induced reserve in CAD patients, indicating that compensatory mechanisms might be exhausted even at moderate altitudes, whereas healthy controls have preserved reserve up to 4500 m. Thus, patients with CAD and impaired CFR should be cautious when performing physical exercise even at moderate altitude.
Revised on June 17, 2003
Accepted on June 18, 2003
Influence of Altitude Exposure on Coronary Flow Reserve
Christophe A. Wyss MD,
2500 m above sea level. We studied the influence of altitude on myocardial blood flow (MBF) in controls and CAD patients.
Key words: blood flow • hypoxia • exercise • coronary disease • tomography
This article has been cited by other articles:
 |
|
 |
|
  B. A. Herzog, L. Husmann, I. Valenta, O. Gaemperli, P. T. Siegrist, F. M. Tay, N. Burkhard, C. A. Wyss, and P. A. Kaufmann Long-Term Prognostic Value of (13)N-Ammonia Myocardial Perfusion Positron Emission Tomography Added Value of Coronary Flow Reserve. J. Am. Coll. Cardiol., July 7, 2009; 54(2): 150 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Kaufmann, A. M. Bernheim, S. Kiencke, M. Fischler, J. Sklenar, H. Mairbaurl, M. Maggiorini, and H. P. Brunner-La Rocca Evidence supportive of impaired myocardial blood flow reserve at high altitude in subjects developing high-altitude pulmonary edema Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1651 - H1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bartsch and J. S. R. Gibbs Effect of Altitude on the Heart and the Lungs Circulation, November 6, 2007; 116(19): 2191 - 2202. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann, O. E. Rimoldi, T. Gnecchi-Ruscone, T. F. Luscher, and P. G. Camici Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2178 - H2182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-P Schmid, M Noveanu, R Gaillet, G Hellige, A Wahl, and H Saner Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease Heart, July 1, 2006; 92(7): 921 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Namdar, P. Koepfli, R. Grathwohl, P. T. Siegrist, M. Klainguti, T. Schepis, R. Delaloye, C. A. Wyss, S. P. Fleischmann, O. Gaemperli, et al. Caffeine Decreases Exercise-Induced Myocardial Flow Reserve J. Am. Coll. Cardiol., January 17, 2006; 47(2): 405 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Brubaker Adventure Travel and Type 1 Diabetes: The complicating effects of high altitude Diabetes Care, October 1, 2005; 28(10): 2563 - 2572. [Full Text] [PDF]
|
|
|
|
|
|
J. Wikstrom, J. Gronros, G. Bergstrom, and L.-m. Gan Functional and Morphologic Imaging of Coronary Atherosclerosis in Living Mice Using High-Resolution Color Doppler Echocardiography and Ultrasound Biomicroscopy J. Am. Coll. Cardiol., August 16, 2005; 46(4): 720 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kaufmann, M. Namdar, F. Matthew, M. Roffi, S. V. Aschkenasy, B. van der Loo, G. Sutsch, T. F. Luscher, and R. Jenni Novel Doppler Assessment of Intracoronary Volumetric Flow Reserve: Validation Against PET in Patients With or Without Flow-Dependent Vasodilation J. Nucl. Med., August 1, 2005; 46(8): 1272 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann, O. Rimoldi, T. Gnecchi-Ruscone, R. S. Bonser, T. F. Luscher, and P. G. Camici Systemic Inhibition of Nitric Oxide Synthase Unmasks Neural Constraint of Maximal Myocardial Blood Flow in Humans Circulation, September 14, 2004; 110(11): 1431 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Possick and M. Barry Evaluation and Management of the Cardiovascular Patient Embarking on Air Travel Ann Intern Med, July 20, 2004; 141(2): 148 - 154. [Abstract] [Full Text] [PDF]
|
|